Ajanta Pharma Ltd. benchmarking: Performance to industry peers

Financial

	Ajanta Pharma	Gland Pharma	Glaxosmithkline Phar
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	75.0 .	388.0 .	n/a
Number of ANDA's Approved By USFDA	56.0 .	337.0 .	n/a
Domestic Sales Growth - YoY	7.5 %	n/a	7.5 %
R&D as a % of Total Sales	5.0 %	4.0 %	0.07 %
Financials
5 yr Average ROE	21.63 %	12.02 %	40.73 %
5yr average Equity Multiplier	1.32	1.15	1.9
5yr Average Asset Turnover Ratio	0.84	0.51	0.94
5yr Avg Net Profit Margin	19.77 %	20.79 %	24.91 %
Price to Book	8.35	3.68	17.19
P/E	35.78	37.1	37.63
5yr Avg Cash Conversion Cycle	-102.34 Days	69.81 Days	-107.65 Days
Inventory Days	55.16 Days	118.26 Days	51.6 Days
Days Receivable	49.8 Days	99.92 Days	22.78 Days
Days Payable	195.69 Days	107.43 Days	144.46 Days
5yr Average Interest Coverage Ratio	108.5	183.05	479.64
5yr Avg ROCE	27.48 %	16.55 %	44.44 %
5yr Avg Operating Profit Margin	27.65 %	29.26 %	25.23 %
5 yr average Debt to Equity	0.0	0.01	0.0
5yr CAGR Net Profit	7.08 %	-6.87 %	20.96 %
5yr Average Return on Assets	16.51 %	10.65 %	21.84 %
Shareholdings
Promoter Holding	66.25 %	51.83 %	75.0 %
Share Pledged by Promoters	17.94 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.14 %	-6.03 %	0.0
Change in Mutual Fund Holding (3 Yrs)	1.45 %	11.53 %	0.77 %

	Ajanta Pharma	Gland Pharma	Glaxosmithkline Phar
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Injectables 0 Pharmaceuticals 0 Vaccines 0	Product Wise Break-Up Injectables 0 Pharmaceutical 0 Vaccines 0 Pharmaceutical 100.0	Product Wise Break-Up Injectables 0 Pharmaceutical 0 Vaccines 24.0 Pharmaceutical 76.0
Segment Break-Up	Segment Break-Up Others 100	-	-
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Dermatology 22.0 Respiratory 0 Hormones 0 Pain/Analgesics 0 Vaccines 0 Anti-Infectives 0 Vitamins/Minerals/Nutrients 0 Others 78.0	-	Therapeutic Area Wise Break-Up - Domestic Hormones 8.91 Vitamins / Minerals / Nutrients 6.47 Respiratory 3.95 Pain Management 11.96 Vaccines 12.64 Dermatology 30.55 Anti-Infective 22.25 Others 3.27
Location Wise Break-Up	Location Wise Break-Up USA 35.74 India 28.59 Asia Pacific 19.39 Africa 16.28 Canada, Australia & New Zealand 0 Australia 0 Canada 0 Europe 0 Rest of the World 0	Location Wise Break-Up Australia 0 Rest of the World 0 India 6.31 Africa 0 Canada, Australia & New Zealand 2.44 Canada 0 USA 70.31 Asia Pacific 0 Europe 5.03 Others 15.91	Location Wise Break-Up Australia 0 Rest of the World 1.35 India 98.65 Africa 0 Canada, Australia & New Zealand 0 Canada 0 USA 0 Asia Pacific 0 Europe 0
Asset Break-Up	Asset Break-Up India 98.73 USA 0.66 Asia Pacific 0.4 Africa 0.21	-	-